Stockreport

Avidity Biosciences GAAP EPS of -$1.27 misses by $0.16, revenue of $12.48M [Seeking Alpha]

Avidity Biosciences, Inc.  (RNA) 
PDF Novartis' Deal For Avidity And Its Late-Stage Muscle Disease Assets Has Caveats Novartis' Avidity Deal: Growth Accretive, Multiple Gated By Execution Avidity Biosci [Read more]